Loading...
Options B.R.O.
Example search prompt
Example search prompt
Example search prompt
Example search prompt
The Indian equity market faced significant selling pressure on March 11, pulling benchmark indices to their lowest levels in nearly a year. The Nifty 50 fell below the 23,900 mark intraday, reflecting cautious investor sentiment across sectors.After a modest rebound in the previous session, marke...
The Indian stock market extended its slide on Monday, 2 March, as the Sensex dropped sharply for the third straight session. The benchmark fell 1,048 points (1.29%), closing at 80,238.85, while the Nifty 50 mirrored the decline, slipping 313 points (1.24%) to end at 24,865.70.This decline marks a...
The Indian stock market faced a sharp correction on March 2, as investors reacted to rising geopolitical tensions between the US and Iran. The Sensex tumbled over 1,000 points, while the Nifty slipped below the 24,900 mark, reflecting a wave of cautious sentiment across the broader market.Global ...
The US-Iran war has suddenly become the biggest trigger for global markets.Overnight, tensions in West Asia escalated sharply. That escalation has unsettled investors worldwide. And when global risk sentiment weakens, Indian markets rarely stay untouched.On Monday, the Indian stock market is like...
Market PerformanceThe latest Sensex and Nifty News paints a cautious picture for Dalal Street.On February 27, Indian benchmark indices ended sharply lower. The selling pressure was not limited to one pocket. It was broad and persistent.At closing bell:Sensex fell 961.42 points or 1.17% to settle ...
Q3 FY26 Performance SnapshotThe Indian pharma sector delivered a steady Q3 FY26, with performance largely driven by domestic strength.Sales Growth: +13% YoYOperating Profit: +12% YoYPAT Growth: +1% YoYWhile revenue and operating profit expanded in tandem, net profit growth remained muted due to m...
Indian equity markets lost momentum in the second half of Wednesday’s trade. After starting the session on a steady note, both benchmark indices slipped from their intraday highs as selling pressure quietly crept back in.By afternoon trade, the mood had turned cautious. Profit-booking emerged in ...
India’s benchmark indices—Sensex and Nifty—broke their six-day winning streak on Friday, dragged down by broad-based selling across key sectors. The caution in markets wasn’t just domestic; global factors like looming US tariffs and Jerome Powell’s awaited Jackson Hole speech kept investors on ed...
Market PerformancePharma stocks witnessed a sharp sell-off on Friday, triggered by new developments from the United States that rattled investor sentiment.The Nifty Pharma index fell over 2.8%, marking its third consecutive day of decline.Sun Pharma led the fall with a 4% drop, becoming the worst...
Market PerformanceThe Indian equity benchmarks extended their upward movement for the second consecutive session on Wednesday, July 30, amid a blend of stock-specific momentum and cautious sentiment.Sensex climbed 144 points (0.18%) to settle at 81,481.86Nifty 50 ended higher by 34 points (0.14%)...
Market PerformanceOn Wednesday, July 16, the Indian stock market indices Sensex and Nifty 50 ended on a flat note, reflecting investor caution amid global uncertainties.Sensex closed 63.57 points or 0.08% higher at 82,634.48Nifty 50 settled 16.25 points or 0.06% higher at 25,212.05Both indices re...
Market PerformanceAfter four consecutive sessions of declines, Indian equity markets experienced a strong rebound on Tuesday, July 15, with both benchmark indices closing in the green.Sensex closed at 82,570.91, up by 317 points or 0.39%Nifty 50 settled at 25,195.80, gaining 114 points or 0.45%Th...
Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...
Market PerformanceIndian stock markets surged on June 16, with Sensex and Nifty snapping a two-day losing streak despite ongoing geopolitical tensions in West Asia.Sensex jumped 677 points or 0.84% to close at 81,796.15Nifty 50 gained 227.90 points or 0.92%, closing at 24,946.50Nifty Midcap 100 a...
Market PerformanceOn May 28, 2025, Indian equity markets experienced another choppy trading session, with the Sensex and Nifty turning red for the second consecutive day. Despite strong cues from Wall Street, domestic markets remained under pressure due to sectoral profit-taking and large block t...
Market PerformanceIndian stock markets ended their two-day winning streak on May 27, witnessing a sharp sell-off led by IT, Auto, and FMCG sectors. The Sensex plummeted by 625 points, while the Nifty 50 slid below the 24,850 mark, reflecting broad-based weakness across industries.Sensex closed at...
Market PerformanceAfter a sharp correction earlier in the week, the Indian stock market saw a strong rebound on May 23, supported by renewed buying from foreign institutional investors (FIIs) and steady inflows from domestic institutional investors (DIIs).Benchmark indices, Nifty and Sensex, rose...
Market PerformanceAfter a sharp dip, Indian equity markets bounced back impressively on May 22, with both Sensex and Nifty posting substantial gains, led by banking, IT, and metal stocks.Sensex closed at 81,721.08, up 769.09 points or 0.95%Nifty settled at 24,853.15, gaining 243.45 points or 0.99...
Market PerformanceSun Pharma's share price experienced a sharp decline of over 4% following its Q4 FY25 earnings release. On Friday, the stock dropped as much as 4.86% to ₹1,636.30 on the BSE.As of 9:25 AM, the share was trading at ₹1,655.00, down 3.78%.Sun Pharma's share price has fallen over 7%...
Market PerformanceThe Nifty Pharma Index witnessed a sharp correction in Monday's early trade, sliding over 2% amid renewed concerns over US drug pricing.The index opened at 20,949.70It dropped to an intraday low of 20,576.05This marked a decline of more than 2% from the previous close of 21,071....
Market OverviewOn April 11, 2025, pharmaceutical shares witnessed a notable upswing following the temporary suspension of reciprocal tariffs by the United States. This development helped reduce recession-related concerns and contributed to optimism in the pharma sector. The Nifty Pharma index rec...
Market PerformanceThe Indian stock market declined on April 3, 2025, following the announcement of reciprocal tariffs by the United States. The Sensex fell by 322.08 points, or 0.42%, to close at 76,295.36. During intraday trading, the index saw a sharp decline of 809.89 points, hitting a low of ...
Market PerformanceOn April 2, U.S. President Donald Trump introduced broad reciprocal tariffs on trade partners, affecting multiple sectors globally. The announcement led to a decline in the Dow Jones Futures by over 1.5% and triggered volatility across international stock markets. The new tariff...
Market PerformanceShares of major Indian pharmaceutical companies increased by 3%- 13% in Thursday's trading session. This movement followed the announcement by U.S. President Donald Trump, who introduced reciprocal tariffs on multiple countries but did not specify any new duties for the pharmace...
Open Free Trading & Demat Account
Trusted by 5.5 Lakh+ Investors
By proceeding, you agree to our Privacy Policy and Terms and Conditions.
Easy & quick
1. Register on SCORES portal
2. Mandatory details for filling complaints on SCORES
Name | PAN | Address | Mobile | Number | E-mail ID
3. Benefits
Effective Communication
Speedy redressal of the grievances
